JP Patent

JP7090639B2 — フッ素置換されたインダゾール化合物及びその使用

Assigned to Sunshine Lake Pharma Co Ltd · Expires 2022-06-24 · 4y expired

What this patent protects

Patent listed against Adempas.

Drugs covered by this patent

Adempas (RIOCIGUAT) · Bayer

Patent Metadata

Patent number: JP7090639B2
Jurisdiction: JP
Classification: —
Expires: 2022-06-24
Drug substance claim: No
Drug product claim: No
Assignee: Sunshine Lake Pharma Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.